Xspray Pharma Licenses Dasatinib Patents to Handa Therapeutics for US and Asian Markets
Xspray Pharma has entered into a license agreement with Handa Therapeutics, granting Handa a non-exclusive license to certain Xspray patents.
Xspray Pharma | 14/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy